TREXIT! Is the end in sight for transrectal prostate biopsy??

Transperineal biopsy has gone from being a fringe pursuit for a bunch of enthusiasts, into primetime in countries like Australia and the UK where it accounts for more than 50% of prostate biopsies. We are joined today by Associate Professor Jeremy Grummet, Urologist at Alfred Health and Monash Medical School, who has been a long-standing proponent of transperineal prostate biopsy, and who contributed to a very nice pro/con debate in European Urology Open Science this month on teh topic of "TREXIT", ie an exit for transrectal prostate biopsy. We credit Dr Rick Popert at Guy's Hospital in London for coning the term. and Dr his colleague Tim O'Brien, President of BAUS, for pushing it onto the national agenda in the UK. This year's EAU Prostate Guidelines changed significantly so that transperineal prostate biopsy is recommended ahead of transrectal biopsy, a huge change, taking transperineal biopsy out of the fringes. So does this signal the end of transrectal biopsy? Or maybe the beginning of the end?? Join Declan, Renu and Jeremy to find out!Plus, Jeremy is also founder and Director of MRI-PRO, a fabulous online resource for those interested in MRI prostate. We hear the latest developments. Links:Eur Urol Open Science paperMRI PROGU Cast with Jeremy Grummet and Lindsay Hampson